SXTC - sxtchina.com Qarzning balans kapitallashuviga nisbati

China SXT Pharmaceuticals, Inc. (SXTC) grafik logotipi

Ushbu grafik China SXT Pharmaceuticals (SXTC) kompaniyasining bozor qiymatini aks ettiradi, u hozirda 0.04 miqdorini tashkil etgan bo'lib, bu Xitoyning an'anaviy tibbiyot ishlab chiqarish zavodlarining modernizatsiyasi va davlat agentliklari orqali savdoning o'sishi bilan ta'minlanmoqda. China SXT Pharmaceuticals (SXTC) sifat standartlarini oshirish orqali shakllangan ichki bozorda o'z mavqeini saqlab qolmoqda, shu bilan birga ekologik filtrlarni joriy etmoqda va tabiiy xomashyolarning kelib chiqishini qat'iy nazorat qilmoqda.

SXTC (China SXT Pharmaceuticals, Inc.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 29.10.2026gacha

sxtchina.com (SXTC) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi China SXT Pharmaceuticals, Inc.|SXTC - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati SXTC|SXTC - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar China SXT Pharmaceuticals|SXTC - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com|SXTC - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati China SXT Pharmaceuticals|SXTC - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati China SXT Pharmaceuticals, Inc.|SXTC - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati SXTC|SXTC - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari China SXT Pharmaceuticals
Kompaniyaning barcha koʻrsatkichlari tahlili:SXTC SXT China
China SXT Pharmaceuticals, Inc. asosiy tovari

Emitentning moliyaviy barqarorligini baholash uchun balansdagi umumiy majburiyatlarning kapitalga nisbati ishlatiladi, bu esa moliyalashtirish tuzilmasining qarz mablag'lariga qanchalik bog'liqligini belgilaydi. GURU.Markets platformasida China SXT Pharmaceuticals (SXTC) uchun qarzning kitob qiymatidagi kapitalizatsiya ko'rsatkichi tahlil qilinishi orqali, investor China SXT Pharmaceuticals Osiyo generik dori vositalari sektorida defolt xavfisiz kengayish uchun o'z kredit yuklamasini qanchalik samarali muvozanatga keltirayotganini ko'rishi mumkin.

China SXT Pharmaceuticals raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati tonixpharma.com (TNXP)|Eupraxia Pharmaceuticals Inc. - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati BioHarvest Sciences, Inc. BHST|Balans kapitallashuviga qarzlar Invizyne Technologies, Inc. (EXOZ)|ORMP - Qarzning sof aktivlarga nisbati|enterabio.com - Balans kapitallashuviga qarzlar|HYFT (ipatherapeutics.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati ABVC BioPharma, Inc. (ABVC)|Qarzning balans qiymatiga nisbati Cumberland Pharmaceuticals Inc|Balans kapitallashuviga qarzlar QNTM|Balans kapitallashuviga qarzlar FibroGen Corporation FGEN|Qarzning balans qiymatiga nisbati Telomir Pharmaceuticals|Rani Therapeutics Holdings - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati SNYR (Synergy CHC Corporation)|Rallybio Corporation (RLYB) - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati lexariabioscience.com|Qarzning balans qiymatiga nisbati Pulmatrix Corporation|Pheton Holdings Limited (PTHL) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Aptorum (APM)|Lyra Therapeutics (LYRA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati IBO (Impact BioMedical, Inc.)|TNF Pharmaceuticals, Inc. (TNFA) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati cbdMD Inc. YCBD|Balans kapitallashuviga qarzlar PainReform Ltd. (PRFX)|CYTO - Qarzning sof aktivlarga nisbati|LIPO: Balans kapitallashuviga qarzlar|OPTN (OptiNose Inc) - Balans kapitallashuviga qarzlar|PIRS - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati PROC|Qarzning balans kapitallashuviga nisbati PTPI (Petros Pharmaceuticals)|Qarzning balans qiymatiga nisbati qlsyy.net (QLI)|Balans kapitallashuviga qarzlar SLRN (ACELYRIN)|Balans kapitallashuviga qarzlar TFF Pharmaceuticals Inc. TFFP